Search

everythinglearnresearchcommunity

for

Search:↓

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Carboxytherapy is a safe and effective treatment for improving skin appearance and treating various skin conditions, with mild side effects.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Plumbagin may help protect cells, reduce inflammation, and has potential for treating various diseases, but more research is needed.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Significant progress has been made in treating skin, hair, and nail disorders in people with skin of color, but disparities still exist.

A protein called desmoglein 3 is important for keeping hair follicle stem cells inactive and helps in their regeneration.

Hyaluronic acid injections can improve mouth opening and quality of life in scleroderma patients.

Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.

Hyaluronic Acid Profhilo® reduces skin inflammation and nerve-related pain in atopic dermatitis.

Exosome-based therapies show promise for treating alopecia areata but need more research.

A new method effectively predicts estrogen-related health effects for early screening.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Skin issues can signal substance use, helping early detection and treatment.

Many women with female pattern hair loss also have metabolic syndrome.

Male pattern baldness worsens with age and can be treated with medications like minoxidil and finasteride, but side effects and personalized care are important.

Several treatments are effective for pigmentary disorders like vitiligo and melasma.

New understanding and treatments for hair loss are improving, but more research is needed.

The conclusion is that a team of skin doctors and psychiatrists is needed to better treat patients with mind-skin disorders.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Secondary syphilis in Cali, Colombia, shows high Treponema pallidum presence and challenges in early diagnosis, needing better public health strategies.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Understanding sex and gender differences can improve personalized dermatology care.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

New treatments like nanotechnology show promise in improving skin cancer therapy.